Bruce Spinowitz Selected Research

sucroferric oxyhydroxide

1/2019	Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
11/2017	One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis.
6/2015	Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce Spinowitz Research Topics

Disease

12	Chronic Renal Insufficiency 01/2021 - 01/2008
8	Anemia 01/2021 - 07/2008
7	Hyperkalemia 01/2022 - 12/2014
4	Hypoxia (Hypoxemia) 01/2021 - 03/2016
4	Heart Failure 01/2021 - 01/2015
2	Hypokalemia 04/2022 - 12/2014
2	Myocardial Infarction 01/2021 - 01/2021
2	Stroke (Strokes) 01/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 10/2019 - 12/2018
2	Inflammation (Inflammations) 10/2019 - 01/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 08/2015
2	Kidney Diseases (Kidney Disease) 11/2017 - 06/2015
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Albuminuria 10/2019
1	Bone Resorption 01/2019
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2019
1	Body Weight (Weight, Body) 12/2018
1	Weight Loss (Weight Reduction) 12/2018
1	Diarrhea 11/2017
1	Vomiting 11/2017
1	Nausea 11/2017
1	Constipation 11/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Pernicious Anemia 01/2017
1	Thrombotic Thrombocytopenic Purpura 01/2017
1	Hemolytic Anemia 01/2017
1	Thrombotic Microangiopathies 01/2017
1	Hepatitis B 08/2015
1	Renal Insufficiency (Renal Failure) 08/2015
1	Hyperphosphatemia 06/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	Edema (Dropsy) 12/2014

Drug/Important Bio-Agent (IBA)

6	sodium zirconium cyclosilicateIBA 04/2022 - 12/2014
5	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2008
3	HematinicsIBA 01/2021 - 03/2016
3	Erythropoietin FDA Link 01/2021 - 01/2018
3	sucroferric oxyhydroxideIBA 01/2019 - 06/2015
3	PotassiumIBA 01/2019 - 12/2014
3	Sevelamer (RenaGel)FDA Link 01/2019 - 06/2015
2	Prolyl-Hydroxylase InhibitorsIBA 01/2021 - 01/2021
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2021
2	vadadustatIBA 01/2021 - 01/2021
2	Darbepoetin alfa (Aranesp)FDA Link 01/2021 - 01/2021
2	bardoxolone methylIBA 10/2019 - 12/2018
2	IronIBA 06/2019 - 01/2018
2	Phosphates (Orthophosphate)IBA 01/2019 - 06/2015
2	Phosphorus (Red Phosphorus)IBA 11/2017 - 06/2015
2	ElectrolytesIBA 01/2015 - 12/2014
2	continuous erythropoietin receptor activator FDA Link 04/2010 - 01/2008
1	AlbuminsIBA 10/2019
1	CreatinineIBA 10/2019
1	Tartrate-Resistant Acid PhosphataseIBA 01/2019
1	MineralsIBA 01/2019
1	HepcidinsIBA 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2017
1	Intrinsic Factor FDA Link 01/2017
1	Blocking AntibodiesIBA 01/2017
1	thiamine triphosphorate (TTP)IBA 01/2017
1	EnzymesIBA 03/2016
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 03/2016
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 08/2015
1	TabletsIBA 06/2015
1	Mineralocorticoid Receptor AntagonistsIBA 01/2015
1	CalciumIBA 01/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015
1	Angiotensin IIIBA 01/2015
1	AldosteroneIBA 01/2015
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2015
1	Renin InhibitorsIBA 01/2015
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2015
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2015
1	patiromerIBA 01/2015
1	ZirconiumIBA 12/2014
1	Epoetin Alfa (Epogen)FDA Link 07/2008

Therapy/Procedure

7	Renal Dialysis (Hemodialysis) 04/2022 - 08/2015
4	Therapeutics 01/2015 - 01/2008
2	Peritoneal Dialysis 08/2015 - 06/2015
1	Erythrocyte Transfusion 06/2019
1	Glycemic Control 12/2018
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 08/2015
1	Intravenous Injections 01/2008